SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-024099
Filing Date
2021-05-05
Accepted
2021-05-05 16:22:37
Documents
14
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgnx-8k_20210505.htm   iXBRL 8-K 35749
2 EX-99.1 rgnx-ex991_24.htm EX-99.1 321400
3 GRAPHIC geewmuyl4don000001.jpg GRAPHIC 15984
  Complete submission text file 0001564590-21-024099.txt   527958

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210505.xsd EX-101.SCH 5764
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210505_lab.xml EX-101.LAB 19469
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210505_pre.xml EX-101.PRE 11621
7 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-8k_20210505_htm.xml XML 3551
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 21893692
SIC: 2836 Biological Products, (No Diagnostic Substances)